Literature DB >> 10927132

Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.

V Grégoire1, E Coche, G Cosnard, M Hamoir, H Reychler.   

Abstract

The increasing use of 3D treatment planning in head and neck radiation oncology has created an urgent need for new guidelines for the selection and the delineation of the neck node areas to be included in the clinical target volume. Surgical literature has provided us with valuable information on the extent of pathological nodal involvement in the neck as a function of the primary tumor site. In addition, few clinical series have also reported information on radiological nodal involvement in those areas not commonly included in radical neck dissection. Taking all these data together, guidelines for the selection of the node levels to be irradiated for the major head and neck sites could be proposed. To fill the missing link between these guidelines and the 3D treatment planning, recommendations for the delineation of these node levels (levels I-VI and retropharyngeal) on CT (or MRI) slices have been proposed using the guidelines outlined by the Committee for Head and Neck Surgery and Oncology of the American Academy for Otolarynology-Head and Neck Surgery. These guidelines were adapted to take into account specific radiological landmarks more easily identified on CT or MRI slices than in the operating field.

Entities:  

Mesh:

Year:  2000        PMID: 10927132     DOI: 10.1016/s0167-8140(00)00202-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  44 in total

Review 1.  Accurate accumulation of dose for improved understanding of radiation effects in normal tissue.

Authors:  David A Jaffray; Patricia E Lindsay; Kristy K Brock; Joseph O Deasy; W A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Development of a Novel Markov Chain Model for the Prediction of Head and Neck Squamous Cell Carcinoma Dissemination.

Authors:  Hyunggu Jung; Anthony Law; Eli Grunblatt; Lucy L Wang; Aaron Kusano; Jose L V Mejino; Mark E Whipple
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

3.  Helical tomotherapy in patients with breast cancer and complex treatment volumes.

Authors:  Ricardo Cendales; Luis Schiappacasse; Franco Schnitman; Graciela García; Hugo Marsiglia
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 4.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

5.  Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.

Authors:  Sandra Schmitz; Jean-Pascal Machiels; Birgit Weynand; Vincent Gregoire; Marc Hamoir
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-22       Impact factor: 2.503

Review 6.  Clinical application of intensity-modulated radiotherapy for head and neck cancer.

Authors:  O Ballivy; R Galiana Santamaría; A Lozano Borbalas; F Guedea Edo
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

Review 7.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

8.  Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.

Authors:  Christopher R Spencer; Hiram A Gay; Bruce H Haughey; Brian Nussenbaum; Douglas R Adkins; Tanya M Wildes; Todd A DeWees; James S Lewis; Wade L Thorstad
Journal:  Cancer       Date:  2014-08-20       Impact factor: 6.860

9.  Radiotherapy-induced xerostomia, pre-clinical promise of LMS-611.

Authors:  Claire Paterson; B Caldwell; S Porteous; A McLean; C M Messow; M Thomson
Journal:  Support Care Cancer       Date:  2015-07-05       Impact factor: 3.603

10.  Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomia.

Authors:  Laura Cerezo; Margarita Martín; Mario López; Alicia Marín; Alberto Gómez
Journal:  Radiat Oncol       Date:  2009-09-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.